Dexamethasone Tablets

Description

Dexamethasone Tablets (0.5mg / 1mg / 2mg / 4mg / 8mg)

Manufactured by: Healthy Life Pharma Pvt. Ltd. (WHO-GMP Certified)
Exported by: Healthy Inc (Star Export House)

1. Product Introduction

Healthy Life Pharma Pvt. Ltd. is a specialized manufacturer of Dexamethasone Tablets in India. Dexamethasone is a potent, long-acting synthetic glucocorticoid used for a range of corticosteroid-responsive inflammatory, allergic, autoimmune, hematologic and other conditions. It has relatively little mineralocorticoid activity compared with some other corticosteroids. Because systemic corticosteroids can cause important dose- and duration-dependent adverse effects, treatment should follow the approved indication and qualified medical supervision.

2. Product Specifications

3. Manufacturing Technology

• Low-Dose Content Uniformity: Validated dispensing, geometric dilution/blending and in-process controls support uniform distribution of Dexamethasone in low-strength tablets.
• Process Selection: Direct compression or other validated manufacturing processes may be used according to formulation characteristics and registered specifications.
• Compression Control: Tablet weight, hardness, friability and disintegration are controlled within approved limits.
• High-Volume Supply: Batch sizes and packaging configurations can be adapted to approved commercial or institutional requirements.

4. Quality Assurance

• Content Uniformity: Dosage-unit uniformity is tested using applicable pharmacopoeial/registered acceptance criteria.
• Dissolution: Release testing follows the approved pharmacopoeial or finished-product specification.
• Assay & Related Substances: Potency, impurities and degradation products are monitored using validated analytical methods.

5. Pharmacology and Clinical Use

Dexamethasone binds intracellular glucocorticoid receptors and alters gene transcription, producing broad anti-inflammatory and immunosuppressive effects.

• Inflammatory / Allergic Disorders: Used for selected severe inflammatory and allergic conditions where systemic corticosteroid treatment is appropriate.
• Cerebral Edema: May be used for specific causes of cerebral edema, particularly tumor-associated edema, under specialist care; it is not appropriate for every cause of brain swelling.
• Respiratory Disease: Used in selected severe inflammatory respiratory conditions. COVID-19 use is indication-specific and generally applies to patients requiring oxygen/respiratory support according to current clinical guidance, not uncomplicated infection.
• Oncology: Used in selected hematologic malignancies and as part of supportive/antiemetic regimens.
• Other Uses: Indications vary by route, formulation and country; obstetric fetal-lung maturation regimens generally use clinician-administered corticosteroid protocols rather than routine self-administered oral tablets.

6. Export and Regulatory Support

• Dossier Support: CTD / ACTD documentation where applicable.
• Certificates: FSC, COPP and COA where applicable.
• Logistics: Air or sea shipment via FOB Mumbai / CIF according to destination-market requirements.

7. Frequently Asked Questions

Q: Who manufactures Dexamethasone Tablets?
A: Healthy Life Pharma Pvt. Ltd. manufactures Dexamethasone tablet formulations in India.

Q: Is Dexamethasone sold under different brands?
A: Yes. Dexamethasone is marketed under multiple brand names. Generic equivalence and interchangeability depend on the specific registered product and applicable regulatory requirements.

Q: Can Dexamethasone cause weight gain?
A: Increased appetite, fluid changes and characteristic fat redistribution can occur, particularly with higher doses or longer treatment. Risk varies with dose, duration and patient factors.

Q: Can Dexamethasone be stopped suddenly?
A: After sufficient systemic exposure, abrupt discontinuation can cause adrenal insufficiency or flare the underlying disease. Whether tapering is needed depends on dose, duration and patient factors and should be decided by the prescriber.

Clinical Pharmacology & Safety Information

(For Registered Medical Practitioners & Patient Reference)

8. Dosage and Administration

• Individualized Dosing: Dose varies widely by indication, disease severity, response, comorbidities and treatment duration. Use the lowest effective dose for the appropriate duration according to the approved prescribing information.
• Tapering: Patients receiving clinically significant systemic corticosteroid exposure may require gradual dose reduction. Do not abruptly stop prolonged or high-dose therapy without medical advice.
• COVID-19 / Acute Illness: Any regimen should follow current evidence-based protocols and clinician direction; Dexamethasone should not be self-started for mild viral illness.
• Administration: Follow the specific product label and prescriber's directions. Taking with food may help reduce gastrointestinal discomfort for some patients.

9. Side Effects and Precautions

• Endocrine / Metabolic: Hyperglycemia, increased appetite, Cushingoid features and hypothalamic-pituitary-adrenal suppression can occur.
• Infection: Corticosteroids can suppress immune responses, increase susceptibility to infection and mask infection symptoms. Appropriate screening and clinical monitoring may be needed.
• Musculoskeletal: Longer-term use can contribute to osteoporosis, fractures, muscle weakness and other complications.
• Psychiatric / Neurologic: Insomnia, mood changes, agitation, depression, euphoria or more severe psychiatric reactions can occur.
• Gastrointestinal: Dyspepsia and ulcer/bleeding risk can be relevant, particularly with NSAIDs or other risk factors.
• Eye: Prolonged corticosteroid exposure can contribute to cataracts, glaucoma and some ocular infections.
• Vaccination: Vaccine decisions, especially live vaccines during immunosuppressive dosing, should follow clinician and product-label guidance.

10. Storage Instructions

• Store below 25°C unless otherwise specified on the registered label.
• Keep in a dry place and protect from excessive light and moisture.
• Keep in original packaging and out of reach of children.